United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

almus pharmaceuticals ltd - trimethoprim - oral tablet - 200mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

phoenix healthcare distribution ltd - trimethoprim - oral tablet - 200mg

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - trimethoprim, quantity: 300 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; povidone; sodium starch glycollate; purified talc; magnesium stearate - this product approved for registration as a variation of a product accepted for inclusion in the artg as 'currently supplied' at the commencement of the act. indications are held in artg paper records. previous product number aust r 17577 and 43120. product information not reviewed. indications as at 5 december 1984 : treatment of acute urinary tract infections caused by sensitive organisms.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - trimethoprim, quantity: 300 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; povidone; sodium starch glycollate type a; purified talc; magnesium stearate

United States - English - NLM (National Library of Medicine)

lupin pharmaceuticals,inc. - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - trimethoprim 100 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of trimethoprim tablets, usp and other antibacterial drugs, trimethoprim tablets, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. for the treatment of initial episodes of uncomplicated urinary tract infections due to susceptible strains of the following organisms: escherichia coli , proteus mirabilis , klebsiella pneumoniae , enterobacter species, and coagulase-negative staphylococcus species, including s. saprophyticus . cultures and susceptibility tests should be performed to determine the susceptibility of the bacteria to trimethoprim. therapy may be initiated prior to obtaining the results of these tests. trimethoprim is contraindicated in individuals hypersensitive to trimethoprim and in those with documented megaloblastic anemia due to folate deficiency.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - trimethoprim - oral tablet - 200mg

United Kingdom - English - myHealthbox

aspen pharma trading limited - sulfamethoxazole/trimethoprim - tablets - 800mg/160mg - combinations of sulfonamides and trimethoprim, incl. derivatives - it is indicated for: treatment and prevention of pneumocystis jiroveci (p. carinii) pneumonitis; treatment and prophylaxis of toxoplasmosis; treatment of nocardiosis; acute uncomplicated urinary tract infection; acute otitis media; acute exacerbation of chronic bronchitis

United Kingdom - English - myHealthbox

aspen pharma trading limited - sulfamethoxazole/trimethoprim - tablets - 80mg/400mg - combinations of sulfonamides and trimethoprim, incl. derivatives - it indicated for: treatment and prevention of pneumocystis jiroveci (p. carinii) pneumonitis; treatment and prophylaxis of toxoplasmosis; treatment of nocardiosis; acute uncomplicated urinary tract infection; acute otitis media; acute exacerbation of chronic bronchitis

Kenya - English - Pharmacy and Poisons Board

medisel kenya ltd box 540-01000 thika - trimetazidine dihydrochloride - tablet - trimetazidine dihydrochloride 35mg - other cardiac preparations

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ausrichter pty ltd - glycine; lysine-l; methionine-dl; hyoscine methobromide; pectin; kaolin light; bismuth subcarbonate; calcium chloride; potassium chloride; magnesium sulfate; sodium acetate; trimethoprim; sulfadiazine; vitamin b2 = riboflavin; vitamin b1 hydrochloride = thiamine hydrochloride - oral tablet - glycine amino acid-glycine active 25.0 mg/100ml; lysine-l amino acid-lysine-l active 12.0 mg/100ml; methionine-dl amino acid-methionine-dl active 20.0 mg/100ml; hyoscine methobromide alkaloid active 10.0 mg/100ml; pectin carbohydrate active 1.38 g/100ml; kaolin light clay active 11.3 g/100ml; bismuth subcarbonate mineral-bismuth active 770.0 mg/100ml; calcium chloride mineral-calcium-salt active 15.0 mg/100ml; potassium chloride mineral-potassium active 20.0 mg/100ml; magnesium sulfate mineral-magnesium active 20.0 mg/100ml; sodium acetate mineral-sodium-salt active 25.0 mg/100ml; trimethoprim pyrimidine active 200.0 mg/100ml; sulfadiazine sulfanyl active 1.0 g/100ml; vitamin b2 = riboflavin vitamin-b2 active 20.0 mg/100ml; vitamin b1 hydrochloride = thiamine hydrochloride vitamin-b1 active 20.0 mg/100ml - alimentary system - calf | cattle | dog | horse | horse foal | beef | beef calf | bitch | bos indicus | bos taurus | bovine | buffalo | bull | bullo - organisms sensitive to sulphadiazine | organisms sensitive to trimethoprim